Exelixis
EXEL
#1647
Rank
A$18.97 B
Marketcap
A$75.48
Share price
-5.25%
Change (1 day)
31.26%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company